Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)

Publication Title

The Journal of urology

Document Type

Article

Publication Date

4-26-2023

Keywords

california; santa monica; sjci; jwci; molecular imaging; positron-emission tomography; prostatic neoplasms

Abstract

PURPOSE: SPOTLIGHT (NCT04186845) evaluated diagnostic performance and safety of radiohybrid

MATERIALS AND METHODS: Men with prostate cancer recurrence underwent positron emission tomography/CT 50-70 minutes after intravenous administration of 296%±20% MBq

RESULTS: The overall

CONCLUSIONS:

Clinical Institute

Cancer

Specialty

Oncology

Specialty

Diagnostic Imaging

DOI

10.1097/JU.0000000000003493

Share

COinS